首页> 外文期刊>Archives of virology >Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens.
【24h】

Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens.

机译:临床样本中人乳头瘤病毒16型E5基因的序列变异和功能分析。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Previously, we found that the E5 protein can be expressed in HPV-16 infected precancerous lesions and cervical cancer. In this study, we investigated the presence of sequence variants of E5 in HPV-16 infected tissues. Toward this end, we amplified the E5 gene by polymerase chain reaction from 29 HPV-16 infected tissues including eight normal tissues, seven high grade neoplastic tissues (high grade squamous intraepithelial lesions (HSIL) and 14 cervical cancer tissues. Sequence analysis demonstrated that there were three mutational hot spots at positions 3979, 4042, and 4077 of the HPV-16 DNA; these and other mutations resulted in six variants in the E5 sequence. This resulted in four E5 protein mutants, named WTE5 [wild type E5 protein], 14E5, 21E5 and 56E5. Functional analysis of these four mutant proteins revealed that the transforming activities of 14E5, 21E5 and 56E5 were 0.95, 0.59, and 0.89 fold of WTE5, respectively. Although E5 was expressed in all of the HSIL and cervical cancer tissues, but in only one of the eight normal tissues tested, only WT E5 protein was found in HSIL while in cervical cancer tissues both WT and mutant E5 proteins were detected. Since these E5 proteins exhibited the same in vitro transforming activity, these data suggest that expression of E5 is important in development and progression toward malignancy but mutation of E5 does not affect the transformation process.
机译:以前,我们发现E5蛋白可以在HPV-16感染的癌前病变和宫颈癌中表达。在这项研究中,我们调查了HPV-16感染组织中E5序列变异的存在。为此,我们通过聚合酶链反应从29个HPV-16感染组织中扩增了E5基因,其中包括8个正常组织,7个高级别肿瘤组织(高级别鳞状上皮内病变(HSIL)和14个宫颈癌组织)。在HPV-16 DNA的3979、4042和4077位置有3个突变热点;这些突变和其他突变导致E5序列出现6个变异,从而产生了4个E5蛋白突变体,称为WTE5(野生型E5蛋白), 14E5、21E5和56E5。对这四个突变蛋白的功能分析表明14E5、21E5和56E5的转化活性分别是WTE5的0.95、0.59和0.89倍,尽管E5在所有HSIL和宫颈癌组织中均表达。 ,但是在测试的八种正常组织中,只有一种在HSIL中发现了WT E5蛋白,而在子宫颈癌组织中则同时检测到WT和突变E5蛋白。同样的体外转化活性,这些数据表明E5的表达在向恶性肿瘤的发展和进展中很重要,但E5的突变并不影响转化过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号